Search Results - "Grech, O."

Refine Results
  1. 1

    Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension by Mollan, S. P., Wakerley, B. R., Alimajstorovic, Z., Mitchell, J., Ottridge, R., Yiangou, A., Thaller, M., Gupta, A., Grech, O., Lavery, G., Brock, K., Sinclair, A. J.

    Published in Journal of headache and pain (01-12-2021)
    “…Objective Headache is the predominant disabler in idiopathic intracranial hypertension (IIH). The aim was to characterise headache and investigate the…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Influence of debrisoquine phenotype and of quinidine on mexiletine disposition in man by Turgeon, J, Fiset, C, Giguère, R, Gilbert, M, Moerike, K, Rouleau, J R, Kroemer, H K, Eichelbaum, M, Grech-Bélanger, O, Bélanger, P M

    “…Mexiletine is a low clearance drug which undergoes extensive metabolism in man. In vitro studies with human liver microsomes have suggested that major…”
    Get more information
    Journal Article
  7. 7

    A Neuro-Ophthalmologist’s Guide to Advances in Intracranial Pressure Measurements by Mollan, Susan P, Momin, Sehrish N.A, Khatkar, Pavan S, Grech, Olivia, Sinclair, Alex J, Tsermoulas, Georgios

    Published in Eye and brain (30-09-2023)
    “…Cerebrospinal fluid disorders have a wide-ranging impact on vision, headache, cognition and a person's quality of life. Due to advances in technology and…”
    Get full text
    Journal Article
  8. 8

    Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination by Turgeon, J, Paré, J R, Lalande, M, Grech-Bélanger, O, Bélanger, P M

    Published in Drug metabolism and disposition (01-09-1992)
    “…Urine samples from control and mexiletine-treated human subjects or rabbits (test group) were collected and passed through an ion exchange resin to isolate…”
    Get more information
    Journal Article
  9. 9

    Stereoselective disposition of mexiletine in man by Grech‐Belanger, O, Turgeon, J, Gilbert, M

    Published in British journal of clinical pharmacology (01-05-1986)
    “…The pharmacokinetics of S‐(+)‐ and R‐(‐)‐mexiletine and of the corresponding conjugates were investigated in six healthy young volunteers after administration…”
    Get full text
    Journal Article
  10. 10

    Deacetylation of diltiazem by rat liver by LeBoeuf, E, Grech-Bélanger, O

    Published in Drug metabolism and disposition (01-01-1987)
    “…The enzyme system mediating the hydrolysis of the calcium antagonist diltiazem to give deacetyldiltiazem was characterized in the rat. Tissue distribution…”
    Get more information
    Journal Article
  11. 11

    Meta-hydroxymexiletine, a new metabolite of mexiletine. Isolation, characterization, and species differences in its formation by Grech-Bélanger, O, Turgeon, J, Lalande, M, Bélanger, P M

    Published in Drug metabolism and disposition (01-03-1991)
    “…Meta-hydroxymexiletine [1-(3-hydroxy,2,6-dimethyl)phenoxy-2-amino-propane], a novel metabolite of the antiarrhythmic drug mexiletine, was isolated from urine…”
    Get more information
    Journal Article
  12. 12
  13. 13

    High pressure liquid chromatographic assay for mexiletine in serum by Grech-Bélanger, O, Turgeon, J, Gilbert, M

    Published in Journal of chromatographic science (01-11-1984)
    “…A highly sensitive, rapid, and specific high pressure liquid chromatographic assay for the analysis of the antiarrhythmic agent mexiletine is reported. The…”
    Get more information
    Journal Article
  14. 14

    Metabolic reduction of 1-nitrosoadamantane by rabbit liver microsomes. Properties of a C-nitroso reductase system by Bélanger, P M, Grech-Bélanger, O

    Published in Drug metabolism and disposition (01-05-1979)
    “…Washed microsomes from rabbit liver reduced 1-nitrosoadamantane to N-hydroxy-1-aminoadamantane in the presence of a cofactor solution under aerobic conditions;…”
    Get more information
    Journal Article
  15. 15

    Depressive effect of amiodarone on hepatic drug metabolism in the rat by Grech-Bélanger, O

    “…The effect of pretreatment of rats with three daily i.p. doses of 25, 50 and 100 mg/kg of the antiarrhythmic agent, amiodarone, on the activity of some hepatic…”
    Get more information
    Journal Article
  16. 16

    Occupational hazards in management of an experimental constructed wetlands by Serafino, L, Bellia, S, Ciantia, F, Grech, O, Luca, N, Milana, E, Bellia, M

    “…The sewage from urban settlements is an important cause of water pollution. Recent Italian legislation offers new possibilities for intervention in the…”
    Get more information
    Journal Article
  17. 17

    Resolution and electrophysiological effects of mexiletine enantiomers by Turgeon, J, Uprichard, A C, Bélanger, P M, Harron, D W, Grech-Bélanger, O

    Published in Journal of pharmacy and pharmacology (01-09-1991)
    “…Resolution of mexiletine enantiomers from the racemic mixture has been achieved by fractional crystallization through the formation of diastereoisomeric…”
    Get more information
    Journal Article
  18. 18

    2,6-Dimethylphenol: a new metabolite of mexiletine by Grech-Bélanger, O, Turgeon, J, Lalande, M

    “…A new metabolite, 2,6-dimethylphenol obtained by O-dealkylation of mexiletine by rabbit liver was identified. A g.c.-f.i.d. method was developed for its…”
    Get more information
    Journal Article
  19. 19

    The effect of fleroxacin on hepatic drug metabolism in the rat by Grech-Bélanger, O, Francoeur, J, Le Bel, M

    “…Pretreatment of rats with repeated i.p. doses of fleroxacin had no effect on the hepatic O- and N-demethylation of p-nitroanisole (PN) and aminopyrine (A)…”
    Get more information
    Journal Article
  20. 20